|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2001-2-8
|
|
pubmed:abstractText |
The aim of this study was to establish the outcome of renal transplantation in patients given pretransplant erythropoietin (EPO) treatment targeted at reaching a normal hemoglobin concentration (Hb), compared to those given EPO-treatment aimed at maintaining subnormal Hb.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
71
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
79-82
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11211199-Adult,
pubmed-meshheading:11211199-Aged,
pubmed-meshheading:11211199-Erythropoietin,
pubmed-meshheading:11211199-Female,
pubmed-meshheading:11211199-Hemoglobins,
pubmed-meshheading:11211199-Humans,
pubmed-meshheading:11211199-Kidney Transplantation,
pubmed-meshheading:11211199-Male,
pubmed-meshheading:11211199-Middle Aged,
pubmed-meshheading:11211199-Time Factors,
pubmed-meshheading:11211199-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
The use of pretransplant erythropoietin to normalize hemoglobin levels has no deleterious effects on renal transplantation outcome.
|
|
pubmed:affiliation |
Department of Medical Sciences, University Hospital, Uppsala, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
